Evidence map›Paper›PMID 42533768›Full record

ArticleChirality2026

Mass Spectrometry in Chiral Analysis and Synthesis.

Brison A Shira, Mahdiyeh Shahi, R Graham Cooks

Abstract read
In one paragraph

Article in Chirality, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. On Serine Octamer Substitution Reactions.Rapid communications in mass spectrometry : RCM · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Brison A ShiraDepartment of Chemistry, Purdue University, West Lafayette, Indiana, USA.ORCID https://orcid.org/0000-0002-5250-5882
Mahdiyeh ShahiDepartment of Chemistry, Purdue University, West Lafayette, Indiana, USA.
R Graham CooksDepartment of Chemistry, Purdue University, West Lafayette, Indiana, USA.ORCID https://orcid.org/0000-0002-9581-9603

Funding

Agilent TechnologiesMultidisciplinary University Research Initiative FA9550-21-1-0170Waters Corporation
6 · The paper itself

Abstract

Mass spectrometry (MS) has a role to play in chiral chemistry, in part through methods based on microdroplets and non-covalent molecular clusters. High-throughput MS reaction screening and chiral anal0ysis use microdroplet sprays to perform accelerated nanoscale chemistry, including the synthesis of heterocyclics and other drug candidates using new high-throughput automated instrumentation. The kinetic method of chiral analysis measures competitive dissociation reactions of molecular clusters (usually trinary coordination complexes) to determine enantiomeric excess (e.e.). A very different molecular cluster, the serine octamer, an active research topic for two decades, may hold implications in the search for the origins of homochirality. Lastly, the recently reported direct discrimination of enantiomers using an ion trap mass spectrometer (ITMS) is revisited. These four examples, combined with recent findings concerning chiral post-translational modifications in cancer biology, represent exciting research developments that deploy the advantages of MS (throughput, molecular specificity, and sample size) to improve chiral synthesis and analysis.

Indexed as

chiral analysisclinical analysishigh‐throughput analysismicrodroplet chemistrymolecular clustersserine octamer

Identifiers

PMID42533768
PMCPMC13425062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.